OIC
IOVA icon

Orion Investment Company’s Iovance Biotherapeutics IOVA Stock Holding History

Orion Investment Company’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.62M Buy
2,073,202
+7,550
+0.4% +$28.7K 2.52% 14
2026
Q1 		$7.25M Buy
2,065,652
+208,718
+11% +$668K 2.3% 15
2025
Q4 		$5.07M Buy
1,856,934
+5,150
+0.3% +$11.9K 1.54% 20
2025
Q3 		$4.02M Sell
1,851,784
-486,779
-21% -$1.15M 1.28% 22
2025
Q2 		$4.02M Buy
2,338,563
+1,161,710
+99% +$2.89M 1.42% 19
2025
Q1 		$3.92M Buy
1,176,853
+116,098
+11% +$599K 1.6% 19
2024
Q4 		$7.85M Buy
1,060,755
+154,470
+17% +$1.43M 3.13% 10
2024
Q3 		$8.51M Buy
906,285
+111,585
+14% +$1.06M 3.31% 9
2024
Q2 		$6.37M Buy
+794,700
New +$8.52M 2.54% 12

Other funds holding IOVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Orion Investment Company's IOVA Position: Q2 2026 in Review

Orion Investment Company increased its Iovance Biotherapeutics (IOVA) stake by 0.37% in Q2 2026, buying an estimated $28.7K and bringing the position to 2,073,202 shares worth $8.62M. The position accounts for 2.52% of the portfolio, ranked #14.

Orion Investment Company first reported a position in IOVA in Q2 2024 and has held it in 9 quarters since. 292 funds tracked by Wall St. Rank hold IOVA as of Q2 2026.

  • Orion Investment Company held 2,073,202 shares of Iovance Biotherapeutics worth $8.62M as of Q2 2026.
  • Orion Investment Company bought 7,550 Iovance Biotherapeutics shares in Q2 2026, an estimated $28.7K.
  • Iovance Biotherapeutics made up 2.52% of Orion Investment Company's portfolio in Q2 2026, its #14 holding.
  • Orion Investment Company first reported a position in Iovance Biotherapeutics in Q2 2024 and has held it in 9 quarters since.
  • 292 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2026.

Based on Orion Investment Company's 13F filing for Q2 2026, filed 11 Aug 2026.